Integrative Genomics of Ageing Group, Institute of Ageing and Chronic Disease, University of Liverpool, William Henry Duncan Building, Room 281, 6 West Derby Street, Liverpool L7 8TX, United Kingdom.
Biogerontology Research Foundation, Research Department, Oxford, United Kingdom.
Exp Gerontol. 2018 Sep;110:230-240. doi: 10.1016/j.exger.2018.06.019. Epub 2018 Jun 20.
Despite the considerable amount of data available on the effect of donor age upon the outcomes of organ transplantation, these still represent an underutilized resource in aging research. In this review, we have compiled relevant studies that analyze the effect of donor age in graft and patient survival following liver, kidney, pancreas, heart, lung and cornea transplantation, with the aim of deriving insights into possible differential aging rates between the different organs. Overall, older donor age is associated with worse outcomes for all the organs studied. Nonetheless, the donor age from which the negative effects upon graft or patient survival starts to be significant varies between organs. In kidney transplantation, this age is within the third decade of life while the data for heart transplantation suggest a significant effect starting from donors over age 40. This threshold was less defined in liver transplantation where it ranges between 30 and 50 years. The results for the pancreas are also suggestive of a detrimental effect starting at a donor age of around 40, although these are mainly derived from simultaneous pancreas-kidney transplantation data. In lung transplantation, a clear effect was only seen for donors over 65, with negative effects of donor age upon transplantation outcomes likely beginning after age 50. Corneal transplants appear to be less affected by donor age as the majority of studies were unable to find any effect of donor age during the first few years posttransplantation. Overall, patterns of the effect of donor age in patient and graft survival were observed for several organ types and placed in the context of knowledge on aging.
尽管有大量关于供体年龄对器官移植结果影响的数据,但这些数据在衰老研究中仍然未得到充分利用。在这篇综述中,我们汇编了相关研究,分析了供体年龄对肝、肾、胰、心、肺和角膜移植后移植物和患者生存的影响,旨在深入了解不同器官之间可能存在的不同衰老速度。总的来说,供体年龄越大,所有研究器官的移植物和患者生存结果越差。然而,供体年龄开始对移植物或患者生存产生负面影响的程度因器官而异。在肾移植中,这个年龄在生命的第三个十年;而心脏移植的数据表明,从 40 岁以上的供体开始就有显著影响。在肝移植中,这个阈值定义不明确,范围在 30 到 50 岁之间。胰腺的结果也表明,供体年龄在 40 岁左右开始产生有害影响,尽管这些结果主要来自于同时进行的胰腺-肾移植数据。在肺移植中,只有 65 岁以上的供体才会产生明显的影响,供体年龄对移植结果的负面影响可能在 50 岁以后开始。角膜移植似乎受供体年龄的影响较小,因为大多数研究都无法在移植后几年内发现供体年龄的任何影响。总的来说,供体年龄对患者和移植物生存的影响模式在几种器官类型中得到了观察,并与衰老知识联系起来。